2007
DOI: 10.1016/j.ophtha.2006.06.042
|View full text |Cite
|
Sign up to set email alerts
|

Macular Retinoblastoma: Evaluation of Tumor Control, Local Complications, and Visual Outcomes for Eyes Treated with Chemotherapy and Repetitive Foveal Laser Ablation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
49
1
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 84 publications
(56 citation statements)
references
References 30 publications
3
49
1
3
Order By: Relevance
“…9 Finally, chemoreduction success varies depending on tumor classification, with more advanced eyes achieving tumor control in 47% to 83% of cases. 10,11 As a result, a greater understanding of tumorigenesis is necessary to develop adjuvant therapies to potentially treat tumors that are unresponsive to current treatment protocols and to minimize local and systemic complications of treatment.…”
mentioning
confidence: 99%
“…9 Finally, chemoreduction success varies depending on tumor classification, with more advanced eyes achieving tumor control in 47% to 83% of cases. 10,11 As a result, a greater understanding of tumorigenesis is necessary to develop adjuvant therapies to potentially treat tumors that are unresponsive to current treatment protocols and to minimize local and systemic complications of treatment.…”
mentioning
confidence: 99%
“…(9,12) Contudo, o estado da doença e os riscos da cirurgia devem ser avaliados individualmente e com rigor. (10,11,15) …”
Section: Discussionunclassified
“…A more recent series reported that 57% of macular tumors treated with chemotherapy and repeat laser ablation retained vision of 20/80 or better. Mean acuity for foveal tumor involvement was 20/100 [2]. Extramacular tumors, on the other hand, maintained vision of 20/25 or better.…”
Section: Reasons For Poor Visual Acuitymentioning
confidence: 94%